Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LSI Medience Corporation
Tokyo, Japanmedience.co.jp ↗
- Ownership
- Private
- Employees
- ~2700
- Development stage
- Other
01
Overview
LSI Medience provides comprehensive clinical testing services, focusing on oncology, genetic testing, and other medical diagnostics. It has partnered with ACT Genomics to enhance genomic profiling in Japan.
- Therapeutic areas
- OncologyInfectious DiseasesRare Diseases
- Modalities
- Genetic TestingOncology TestingBiochemical TestingImmunological TestingMicrobiological TestingPathological Testing
- Industry
- Molecular Diagnostics
02
Partnerships
ACT Genomics for genomic profiling and personalized medicine in Japan
Beyond the preview
Go deeper on LSI Medience Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LSI Medience Corporation.